World News
-
Facebook, NYU to initiate fastMRI using AI
World | News | 0 Comment | 24 Aug, 2018
Facebook has partnered with New York University (NYU) School of Medicine to initiate a research project focused on lever...Read more
-
FDA approves first drug for neurotrophic keratitis
World | News | 0 Comment | 23 Aug, 2018
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...Read more
-
World | News | 0 Comment | 23 Aug, 2018
Singapore- DexCom, leader in continuous glucose monitoring for people with diabetes, announced today that it has acquire...Read more
-
Bluebird, Gritstone inks deal to develop cancer cell therapies
World | News | 0 Comment | 23 Aug, 2018
Singapore- Bluebird Bio and Gritstone Oncology collaborates to research, develop and commercialize products for the trea...Read more
-
Philips introduces new cardiovascular ultrasound system
World | News | 0 Comment | 23 Aug, 2018
Royal Philips, a global leader in health technology, has introduced the EPIQ CVx cardiovascular ultrasound system. Built...Read more
-
GIC receives govt funding for immuno-oncology project
World | News | 0 Comment | 22 Aug, 2018
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...Read more
-
World | News | 0 Comment | 21 Aug, 2018
Singapore - Achillion Pharmaceuticals appoints Steven Zelenkofske, D.O. to the position of Executive Vice President...Read more
-
Researchers develop predictor for immunotherapy response in melanoma
World | News | 0 Comment | 21 Aug, 2018
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patie...Read more
-
FDA grants orphan drug status to ASLAN’s treatment for AML
World | News | 0 Comment | 20 Aug, 2018
Singapore - ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly pre...Read more
-
Tolero Pharmaceuticals collaborates with AbbVie for AML trial
World | News | 0 Comment | 20 Aug, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...Read more
-
Verana Health Announces $30M Series C Financing
World | News | 0 Comment | 20 Aug, 2018
Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade speci...Read more
-
FDA approves first generic version of EpiPen
World | News | 1 Comment | 17 Aug, 2018
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...Read more
-
Scientists develop platform to kill cancer cells
World | News | 0 Comment | 17 Aug, 2018
An interdisciplinary group of scientists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Re...Read more
-
Dr Sundar receives an honor of first female President of BGCS
World | News | 0 Comment | 16 Aug, 2018
University of Birmingham women’s cancer expert Dr Sudha Sundar has been chosen as the President-Elect of the Briti...Read more
-
rfxcel enhances Pharmaceutical Track and Trace Solution for Russia
World | News | 0 Comment | 16 Aug, 2018
rfxcel, the global leader in track and trace solutions, releases enhancements to its compliance solution for Russia and ...Read more
-
Multi- institutional alliance to develop anti-aging drugs
World | News | 0 Comment | 16 Aug, 2018
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...Read more
-
Mylan brings first generic for Adcirca tablets
World | News | 0 Comment | 14 Aug, 2018
Global pharmaceutical company Mylan N.V. has announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the f...Read more
-
Orchard Therapeutics raises $150 M to improve Gene Therapy Pipeline
World | News | 0 Comment | 13 Aug, 2018
Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare disea...Read more
